Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 951-985-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Data summary of skin and eye irritation and corrosion studies.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental Phase: 08 July 2020 to 13 July 2020.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Deviations:
- no
- GLP compliance:
- yes
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- Supplier: EpiSkin Laboratories, Lyon, France.
Date received: 07 July 2020
EpiSkinTM Tissues (0.38cm2)
Lot number: 20-EKIN-028
Maintenance Medium lot number: 20-MAIN3-018
Assay Medium lot number: 20-ESSC-018
Main Test
Application of Test Item and Rinsing (Day 1)
Triplicate tissues were treated with the test item for an exposure period of 15 minutes. 5 µL of sterile distilled water was topically applied to the epidermal surface in order to improve contact between the test item and the epidermis. Approximately 10 mg (26.3 mg/cm test item was then applied to the epidermal surface ensuring uniform covering. Triplicate tissues treated with 10 µL of DPBS served as the negative controls and triplicate tissues treated with 10 µL of SDS 5% w/v served as the positive controls.
The plates were kept in the biological safety cabinet at room temperature for 15 minutes.
At the end of the exposure period, each tissue was removed from the well using forceps and rinsed using a wash bottle containing DPBS to gently remove any residual test item. The rinsed tissues were transferred to the second column of 3 wells containing 2 mL of maintenance medium in each well. The rinsed tissues were incubated at 37°C, 5% CO2 in air for 42 hours.
MTT Loading/Formazan Extraction (Day 3)
Following the 42-hour post-exposure incubation period each 12-well plate was placed onto a plate shaker for 15 minutes to homogenize the released mediators in the maintenance medium. 1.6 mL of the maintenance medium from beneath each tissue was transferred to pre-labelled micro tubes and stored in a freezer (-35 to -10 ºC) for possible inflammatory mediator determination.
2 mL of MTT solution, freshly prepared in assay medium, was pipetted into the third column of 3 wells of the 12-well plates. The tissues were transferred to the MTT filled wells with any excess maintenance medium from the bottom of the tissue insert removed by blotting on absorbent paper. The tissues were incubated for 3 hours at 37 °C,5% CO2 in air. At the end of the 3-hour incubation period each tissue was placed onto absorbent paper to dry. A total biopsy of the epidermis was made using the EPISKIN biopsy punch. The epidermis was carefully separated from the collagen matrix using forceps and both parts (epidermis and collagen matrix) placed into labelled 1.5 mL micro tubes containing 500 µL of acidified isopropanol, ensuring that both the epidermis and collagen matrix were fully immersed. Following mixing on a vortex mixer the tubes were refrigerated at 2 to 10 °C until Day 6 of the experiment, allowing the extraction of formazan crystals out of the MTT-loaded tissues.
Absorbance/Optical Density Measurements (Day 6)
At the end of the formazan extraction period each tube was mixed thoroughly on a vortex mixer to produce a homogenous coloured solution.
For each tissue, duplicate 200 µL samples were transferred to the appropriate wells of a 96-well plate. 200 µL of acidified isopropanol alone was added to the two wells designated as ‘blanks’. The optical density (OD570) was measured (quantitative viability analysis) at 570 nm (without a reference filter) using a Labtech LT-4500 microplate reader. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- Approximately 10 mg (26.3 mg/cm) test item was then applied to the epidermal surface ensuring uniform covering.
- Duration of treatment / exposure:
- 15 minutes
- Duration of post-treatment incubation (if applicable):
- The post-exposure incubation period was 42-hour.
- Number of replicates:
- Tripilcate tissues were treated for the test item and positive and negative controls.
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Test Item
- Value:
- 95.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- ACCEPTANCE CRITERIA
The relative mean tissue viability for the positive control treated tissues was 2.8% relative to the negative control treated tissues and the standard deviation value of the viability was 0.5%. The positive control acceptance criteria were therefore satisfied.
The mean OD570 for the negative control treated tissues was 0.845 and the standard deviation value of the viability was 9.8%. The negative control acceptance criteria were therefore satisfied.
The standard deviation calculated from individual tissue viabilities of the three identically test item treated tissues was 1.8%. The test item acceptance criterion was therefore satisfied. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study and under the experimental conditions reported, the test item was classified as non-irritant. The following classifications apply: EU CLP Not classified for Irritation. UN GHS Not classified for Irritation (category 3 cannot be determined).
- Executive summary:
Introduction
The purpose of this test was to evaluate the skin irritation potential of the test item using the EPISKINTM reconstructed human epidermis model. The test was designed to be compatible with the following guidelines:
- OECD Guideline for the Testing of Chemicals No. 439 In Vitro Skin Irritation: Reconstructed Human EpiDermis (RHE) Test Method (18 June 2019)
- Method B.46. in vitro skin irritation: Reconstructed Human Epidermis Model Test as described in Commission Regulation (EC) No. 640/2012, of 06 July 2012 amending, for the purpose of its adaption to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No. 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
Method
Triplicate tissues were treated with the test item for an exposure period of 15 minutes. At the end of the exposure period each tissue was rinsed before incubating for 42-hours. At the end of the post-exposure incubation period each tissue was taken for MTT-loading. The maintenance medium from beneath each tissue was transferred to pre-labelled micro tubes and stored in a freezer for possible inflammatory mediator determination. After MTT-loading a total biopsy of each epidermis was made and placed into micro tubes containing acidified isopropanol for extraction of formazan crystals out of the MTT-loaded tissues.
At the end of the formazan extraction period each tube was mixed thoroughly and duplicate 200 µL samples were transferred to the appropriate wells of a pre-labelled 96-well plate. The optical density was measured at 570 nm.
Data are presented in the form of percentage viability (MTT reduction in the test item treated tissues relative to negative control tissues).
Results
The relative mean viability of the test item treated tissues was 95.6% after the 15-Minute exposure period and 42-Hours post-exposure incubation period.
Conclusion
In this study and under the experimental conditions reported, the test item was classified as non-irritant. The following classifications apply: EU CLP Not classified for Irritation. UN GHS Not classified for Irritation (category 3 cannot be determined).
- OECD Guideline for the Testing of Chemicals No. 439 In Vitro Skin Irritation: Reconstructed Human EpiDermis (RHE) Test Method (18 June 2019)
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental Phase: 02 June 2020 to 04 June 2020.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Method B.40bis of Commission Regulation (EC) No 440/2008, of 30 May 2008.
- Deviations:
- no
- GLP compliance:
- yes
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Vehicle:
- other: 25 µL of sterile water was added for wetting of the test item to increase tissue surface contact.
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: MatTek MTT 100 kit from MatTek In Vitro Life Sciences Laboratories
- Tissue lot number: 30870
- Delivery date: 02 June 2020
- Date of initiation of testing: 02 June 2020
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 °C, 5% CO2
PRE-INCUBATION
The assay medium was brought to room temperature before use. 0.9 mL of this assay medium was pipetted into the appropriate wells of two pre-labeled 6-well plates for both the 3 Minute and 60 Minute exposure periods. EpiDerm™ tissues were transferred into the 6 well plates containing the assay medium. The 6 well plates containing the EpiDerm™ samples were pre-incubated (37 °C, 5% CO2) for approximately 1 hour before dosing.
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps:
Rinsing was achieved by filling and emptying each tissue under a constant soft stream of Dulbecco’s Phosphate Buffered Saline (DPBS) (without Ca++ Mg++) for approximately 40 seconds, to gently remove any residual test item. Excess DPBS was removed by blotting the bottom of the tissue insert with tissue paper. Each tissue was placed into the prepared holding plate until all tissues were rinsed. They were then blotted and transferred to the 24 well plate prepared for MTT-loading.
- Observable damage in the tissue due to washing:
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- Incubation time: 3 hours
- Spectrophotometer: Labtech LT 4500 microplate reader and LT-com analysis software
- Wavelength: 570nm
NUMBER OF REPLICATE TISSUES:
Duplicate for each treatment
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- As given in OECD 431 test guideline. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 25 mg
- Concentration (if solution): 25 µL of sterile water was added for wetting of the test item to increase tissue surface contact.
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 50 µL
- Concentration (if solution): 100%
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 50 µL
- Concentration (if solution): 8.0N Potassium Hydroxide - Duration of treatment / exposure:
- 1 x 3 minute exposure period
1 x 60 minute exposure period - Duration of post-treatment incubation (if applicable):
- None
- Number of replicates:
- Testing was conducted in duplicate for each tretment.
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3 minute exposure period
- Value:
- 98.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100% tissue viability
- Positive controls validity:
- valid
- Remarks:
- 3.5% tissue viability
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60 minute Exposure Period
- Value:
- 98.9
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100% tissue viabilty
- Positive controls validity:
- valid
- Remarks:
- 2.6% tissue viability
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Direct-MTT reduction: The MTT solution containing the test item did not turn blue/purple. This was taken to indicate the test item did not reduce MTT.
- Colour interference with MTT: The solution containing the test item did not become coloured. This was taken to indicate the test item did not have the potential to cause colour interference.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions used in the study the test item was considered to be non-corrosive to the skin.
- Executive summary:
Introduction
The purpose of the study was to evaluate the corrosivity potential of the test item using the EpiDerm™ Human Skin Model Corrosion is directly related to cytotoxicity in the EpiDerm™ tissue. The test method was designed to be meet the requirements of the following guidelines:
-
OECD Guideline for the Testing of
Chemicals No. 431 In Vitro Skin Corrosion: Reconstructed Human
EpiDermis (RHE) Test Method (18 June 2019)
- Method B.40bis of Commission Regulation (EC) No 440/2008, of 30 May 2008, laying down test methods pursuant to Regulation (EC) No 1907/2006, 18 December 2006, of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
Methods
Duplicate tissues were treated with the test item for exposure periods of 3 and 60 minutes. Negative and positive control groups were treated for each exposure period. At the end of the exposure period the test item was rinsed from each tissue before each tissue was taken for MTT‑loading. After MTT-loading each tissue was placed in 2 mL of isopropanol for MTT extraction.
At the end of the formazan extraction period triplicate 200 mL samples were transferred to the appropriate wells of a pre-labeled 96‑well plate. The optical density (OD) was measured at 570 nm (OD570).
Results
The relative mean viabilities for each treatment group were as follows:
Exposure Period Percentage Viabilty Negative Control Positve Control Test Item 3 minute 100* 3.5 98.3 60 minute
100* 2.6 98.9
*The mean viability of the negative control tissues is set at 100%
Conclusion
Under the experimental conditions used in the study the test item was considered to be non-corrosive to the skin.
-
OECD Guideline for the Testing of
Chemicals No. 431 In Vitro Skin Corrosion: Reconstructed Human
EpiDermis (RHE) Test Method (18 June 2019)
Referenceopen allclose all
Direct MTT Reduction
The MTT solution containing the test item did not turn blue or purple which indicated that the test item did not directly reduce MTT.
Assessment of Colour Interference with the MTT endpoint
The solution containing the test item was colourless. It was therefore unnecessary to run colour correction tissues.
Results
The relative mean viabilities for each treatment group were as follows:
Exposure Period | Percentage Viabilty | ||
Negative Control | Positve Control | Test Item | |
3 minute | 100* | 3.5 | 98.3 |
60 minute |
100* | 2.6 | 98.9 |
*The mean viability of the negative control tissues is set at 100%
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental phase start and completion: 07 July 2020.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- cattle
- Details on test animals or tissues and environmental conditions:
- Source of Bovine Eyes
Eyes from adult cattle (typically 12 to 60 months old) were obtained from a local abattoir as a by-product from freshly slaughtered animals. The eyes were excised by an abattoir employee after slaughter, and were placed in Hanks’ Balanced Salt Solution (HBSS) supplemented with antibiotics (penicillin at 100 IU/mL and streptomycin at 100 µg/mL). They were transported to the test facility over ice packs on the same day of slaughter. The corneas were prepared immediately on arrival.
Preparation of Corneas
All eyes were macroscopically examined before and after dissection. Only corneas free of damage were used.
The cornea from each selected eye was removed leaving a 2 to 3 mm rim of sclera to facilitate handling. The iris and lens were peeled away from the cornea. The isolated corneas were immersed in a dish containing HBSS until they were mounted in Bovine Corneal Opacity and Permeability (BCOP) holders.
The anterior and posterior chambers of each BCOP holder were filled with complete Eagle’s Minimum Essential Medium (EMEM) without phenol red and plugged. The holders were incubated at 32 ± 1 ºC for 70 minutes. At the end of the incubation period each cornea was examined for defects. Only corneas free of damage were used.
- Vehicle:
- physiological saline
- Remarks:
- For the purpose of this study the test item was prepared as a 20% w/v solution in sodium chloride 0.9% w/v.
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- .TEST MATERIAL
- Concentration (if solution): 0% w/v solution in sodium chloride 0.9% w/v
NEGATIVE CONTROL
The negative control item, sodium chloride 0.9% w/v, was used as supplied.
POSITIVE CONTROL
The positive control item, Imidazole, was used as a 20% w/v solution in sodium chloride 0.9% w/v. - Duration of treatment / exposure:
- 240 minutes
- Number of animals or in vitro replicates:
- Three replicates (corneas) per treatment (test substance, negative control, positive control).
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
QUALITY CHECK OF THE ISOLATED CORNEAS : Yes
NUMBER OF REPLICATES: Three per treatment
NEGATIVE CONTROL USED : Sodium Chloirde 0.9% w/v
SOLVENT CONTROL USED (if applicable): No
POSITIVE CONTROL USED: Imidiazole
APPLICATION DOSE AND EXPOSURE TIME : 240 minutes
POST-INCUBATION PERIOD: No
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: 3 washings with fresh complete EMEM containing phenol red before a final rinse with complete EMEM without phenol red
- POST-EXPOSURE INCUBATION: No
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Opacitometer (calibrated on the day of the test)
- Corneal permeability: passage of sodium fluorescein dye measured using microtiter plate reader at 492nm (without a reference filter)
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
DECISION CRITERIA: As specified in the test guideline. - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- Test Substance (mean of three replicates)
- Value:
- 1
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Remarks:
- in vitro irritancy score = 0.3
- Positive controls validity:
- valid
- Remarks:
- in vitro irritancy score = 92.4
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the test, the test item is given No Category classification according to the UN GHS classification scheme.
- Executive summary:
Introduction
The ability of the test item to induce eye damage was assessed using a method designed to meet the requirements of the following guidelines:
- OECD Guideline for the Testing of Chemicals No. 437 (updated 09 October 2017) “Bovine Corneal Opacity and Permeability Assay”
- Method B.47 of Commission Regulation (EC) No. 440/2008
Method
The test item was applied at a concentration of 20% w/v in sodium chloride 0.9% w/v for 240 minutes. Negative and positive control items were tested concurrently. The two endpoints, decreased light transmission through the cornea (opacity) and increased passage of sodium fluorescein dye through the cornea (permeability) were combined in an empirically derived formula to generate an In Vitro Irritancy Score (IVIS). Three corneas were used per treatment group.
Data Interpretation
The test item is classified according to the followign criteria:
IVIS UN GHS ≤ 3 No Category >3 ≤ 55 No prediction can be made > 55 Category 1 Results
The In Vitro irritancy scores are summarised as follows:
Treatment In Vitro Irritancy Score Test Item 1.0 Negative Control 0.3 Positive Control 92.4
Conclusion
Under the conditions of the test, the test item is given No Category classification according to the UN GHS classification scheme.
Reference
The test item is classified according to the following criteria:
IVIS | UN GHS |
≤ 3 | No Category |
>3 ≤ 55 | No prediction can be made |
> 55 | Category 1 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
The EPISKIN skin irritation test and Epiderm skin corrosion tests did not meet the criteria for classification for skin effects according to Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures.
The BCOP test gave a 'no category' result for eye effects and therefore the substance is not classified for eye effects according to Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.